Last reviewed · How we verify
Olumacostat Glasaretil Gel, 7.5%
Olumacostat Glasaretil Gel, 7.5% is a Small molecule drug developed by Dermira, Inc.. It is currently in Phase 1 development. Also known as: DRM01.
At a glance
| Generic name | Olumacostat Glasaretil Gel, 7.5% |
|---|---|
| Also known as | DRM01 |
| Sponsor | Dermira, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris (PHASE2)
- A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Olumacostat Glasaretil Gel, 7.5% CI brief — competitive landscape report
- Olumacostat Glasaretil Gel, 7.5% updates RSS · CI watch RSS
- Dermira, Inc. portfolio CI
Frequently asked questions about Olumacostat Glasaretil Gel, 7.5%
What is Olumacostat Glasaretil Gel, 7.5%?
Olumacostat Glasaretil Gel, 7.5% is a Small molecule drug developed by Dermira, Inc..
Who makes Olumacostat Glasaretil Gel, 7.5%?
Olumacostat Glasaretil Gel, 7.5% is developed by Dermira, Inc. (see full Dermira, Inc. pipeline at /company/dermira-inc).
Is Olumacostat Glasaretil Gel, 7.5% also known as anything else?
Olumacostat Glasaretil Gel, 7.5% is also known as DRM01.
What development phase is Olumacostat Glasaretil Gel, 7.5% in?
Olumacostat Glasaretil Gel, 7.5% is in Phase 1.
Related
- Manufacturer: Dermira, Inc. — full pipeline
- Also known as: DRM01
- Compare: Olumacostat Glasaretil Gel, 7.5% vs similar drugs
- Pricing: Olumacostat Glasaretil Gel, 7.5% cost, discount & access